EOSU: Unblinding Of Cases Where Patient Receives Two Treatment Drugs
(Doc ID 1360403.1)
Last updated on DECEMBER 05, 2019
Applies to:Oracle Argus Unblinding - Version 4.2.0 to 7.0.0 [Release 4.2.0 to 7.0.0]
Information in this document applies to any platform.
Unable to unblind cases where patient has received two drugs as treatment received. The study for these cases has multiple study drugs configured.
Steps to Repeat:
(1) Create study with following study drugs:
StudyID: EOSU Test
Study Products: Drug A, Drug B & Placebo
(2)Create CT cases using study EOSU Test
(3) Create treatment randomization file
- 2 treatment rows for each patient
(4) Configure EOSU Profile for EOSU Test
(5) Load Randomization file
(6) Product Mapping
Drug A - A
Drug B - B
Placebo - C
(7) Dry run profile
(8) Observe the following entry in the exception report:
"Duplicate entries in Randomization Data (Study+Rand#/Patient ID) are matching the Case Data."
To view full details, sign in with your My Oracle Support account.
Don't have a My Oracle Support account? Click to get started!
In this Document